The Clinical,Radiologic,Pathologic and Molecular Marker Characteristics of Pancreatic Cysts Study

Completed

Conditions studied: Pancreatic Cysts, Pancreatic Cancer

In brief

The aim is to propose and prospectively validate a diagnostic approach and model for prediction of mucinous versus non-mucinous, and malignant versus non-malignant pancreatic cysts using a combination of clinical, radiologic, and biomarker characteristics.

Key facts

Study ID

NCT01202136

Run by

Johns Hopkins University

People needed

477

Starts

2012-10-01

Expected to finish

2019-09-01

Last updated by the study team

2026-02-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adult patients age 18 years and older
• Referred for assessment of one or more pancreatic cyst.

You may not qualify if…

• Medically ill patients with ASA class 4 or greater.
• History of chronic kidney disease with a serum creatinine > 2.0 mg/dl or estimated glomerulofiltration rate (eGFR) < 30 ml/min, dialysis patients, acute renal failure, cirrhosis of the liver, chronic hepatitis, prior nephrectomy or kidney or liver transplantation.
• History of moderate (generalized hives) or severe (facial swelling, airway reaction) reaction to intravenous radiographic contrast material.
• History of obstruction in the upper GI tract such as esophageal or pyloric stricture, which would not allow passage of an endoscope.
• Bleeding diathesis (clotting problems) or a history of thrombocytopenia (low platelet count <50,000).
• Inability to provide informed consent.
• Pregnancy or lactation.

Where it is running

• Johns Hopkins Hospital — Baltimore, Maryland, United States
• Johns Hopkins Medicine — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.